11 Results for "

GluN1/GluN2B

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "GluN1/GluN2B" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-13457
CAS No.: 852918-02-6
Purity:  99.06%
Target:  

iGluR

Research Areas:  

Neurological Disease

TCN 201 is a potent, selective and non-competitive antagonist of GluN1/GluN2A NMDA receptor, with a pIC50 of 6.8. TCN 201 is selective for GluN1/GluN2A NMDA receptor over GluN1/GluN2B NMDA receptor (pIC50<4.3) [1] [2].
loading...
    loading...
Cat. No.: HY-124569
CAS No.: 1237541-73-9
Purity:  98.26%
Target:  

iGluR

Research Areas:  

Neurological Disease

NAB-14 is a potent, selective, orally active and non-competitive GluN2C/2D antagonists with an IC50 of 580 nM for GluN1/GluN2D. NAB-14 shows >800-fold selective for recombinant GluN2C and GluN2D over GluN2A and GluN2B. NAB-14 can cross the blood-brain-barrier [1].
loading...
    loading...
Cat. No.: HY-112095
CAS No.: 627525-33-1
Synonyms: ENS-101 free base
Target:  

iGluR

Research Areas:  

Neurological Disease

EVT-101 free base is a GluN2B antagonist. EVT-101 free base binds at the same GluN1/GluN2B dimer interface as Ifenprodil (HY-12882). EVT-101 free base inhibits calcium influx in chicken-derived cells, with an EC50 of 22 nM. EVT-101 can be used in the research of brain disorders [1] [2].
loading...
    loading...
Cat. No.: HY-179108
Target:  

iGluR

Research Areas:  

Neurological Disease

NMDAR modulator 1 (Compound 12) is a positive, allosteric GluN1/GluN2B receptor modulator. NMDAR modulator 1 enhances NMDAR current. NMDAR modulator 1 can be used in the research of psychiatric disorders [1].
loading...
    loading...
Cat. No.: HY-169951
CAS No.: 2577196-14-4
Target:  

iGluR

Research Areas:  

Neurological Disease

Lu AF90103 (Compound 42e) is a methyl ester prodrug of compound 42d capable of penetrating the blood-brain barrier. Compound 42d acts as a partial agonist of the GluN1/GluN2B complex, exhibiting 24% efficacy, and has an EC50 value of 78 nM. Lu AF90103 plays an important role in neuropsychiatric diseases research [1].
loading...
    loading...
Cat. No.: HY-120523
CAS No.: 1333213-35-6
Target:  

iGluR

Research Areas:  

Neurological Disease

UBP646 is a potent GluN1/GluN2D receptors potentiator, and also potentiates the other three subtypes, GluN1/GluN2A, GluN1/GluN2B, and GluN1/GluN2C receptors [1].
loading...
    loading...
Cat. No.: HY-169950
CAS No.: 2576586-47-3
Target:  

iGluR

Research Areas:  

Neurological Disease

NMDA agonist 1 (compound 42d) is a potent NMDA agonist with a Ki value of 96 nM. NMDA agonist 1 acts as a partial agonist of the GluN1/GluN2B complex with an EC50 value of 78 nM [1].
loading...
    loading...
Cat. No.: HY-172213
CAS No.: 1585965-04-3
Target:  

iGluR

Research Areas:  

Neurological Disease

(3S,6R)-NML is a NMDA receptor antagonist, with pIC50s of 4.8 (GluN1-GluN2A), 4.6 (GluN1-GluN2B), 5.0 (GluN1-GluN2C), 5.0 (GluN1-GluN2D) respectively. (3S,6R)-NML can be used for depression research [1].
loading...
    loading...
Cat. No.: HY-172884
Research Areas:  

Neurological Disease

MDAR IN-1 (Compound 5m) is a brain-penetrant inhibitor of acetylcholinesterase (AChE) and antagonist of the GluN1/GluN2B subtype of NMDAR receptor. MDAR IN-1 effectively inhibits AChE activity, enhances cholinergic neurotransmission, and blocks NMDAR, reducing excitatory neurotoxicity. MDAR IN-1 is promising for research of Alzheimer's disease [1].
loading...
    loading...
Cat. No.: HY-155733
Research Areas:  

Neurological Disease

AChE/Aβ-IN-1 (compound 32) is a potent and orally active inhibitor of acetylcholinesterase (AChE) with an IC50 of 86 nM, as well as an antagonist of NMDA receptor (GluN1-1b/GluN2B subunit combination) with IC50 of 3.876 μM. AChE/Aβ-IN-1 also inhibits Aβ aggregation and shows good blood-brain barrier permeability and neuroprotection. AChE/Aβ-IN-1 improves cognitive and spatial memory impairment in rats model [1].
loading...
    loading...
Cat. No.: HY-155735
Research Areas:  

Neurological Disease

AChE/Aβ-IN-2 (compound 33) is a potent and orally active inhibitor of acetylcholinesterase (AChE) with IC50 of 135 nM, as well as an antagonist of NMDA receptor (GluN1-1b/GluN2B subunit combination) with IC50 of 5.054 μM. AChE/Aβ-IN-2 also inhibits Aβ aggregation and shows good blood-brain barrier permeability. AChE/Aβ-IN-2 improves cognitive and spatial memory impairment in rats model [1].
loading...
    loading...
  • 1